Thetis using 'salty' chemistry to transform diabetes care
By Marie Powers
Wednesday, August 26, 2015
In his 35 years at Pfizer Inc., including tenure as the New York-based pharma's director of R&D operations, Frank Sciavolino was immersed in the science side of the business and didn't necessarily see himself in the role of a CEO.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.